Group One Trading’s Vor Biopharma VOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-14,900
Closed -$266K – 8598
2026
Q1
$266K Sell
14,900
-70,100
-82% -$989K ﹤0.01% 3891
2025
Q4
$1.11M Sell
85,000
-11,400
-12% -$212K ﹤0.01% 2786
2025
Q3
$4.7M Buy
+96,400
New +$3.88M 0.01% 1534
2025
Q2
– Sell
-420
Closed -$6.03K – 8722
2025
Q1
$6.03K Hold
420
– – ﹤0.01% 6567
2024
Q4
$9.32K Buy
+420
New +$6.96K ﹤0.01% 6134
2024
Q3
– Sell
-10
Closed -$200 – 7426
2024
Q2
$200 Hold
10
– – ﹤0.01% 6520
2024
Q1
$474 Buy
+10
New +$439 ﹤0.01% 6747

Other funds holding VOR

Group One Trading's VOR Position: Q3 2026 in Review

Group One Trading reduced its Vor Biopharma (VOR) stake by 4.4% in Q3 2026, selling an estimated $2.75K and leaving 2,834 shares worth $54.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5185.

Group One Trading first reported a position in VOR in Q4 2023 and has held it in 8 quarters since. The position peaked at $162K in Q1 2026. 154 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • Group One Trading held 2,834 shares of Vor Biopharma worth $54.1K as of Q3 2026.
  • Group One Trading sold 129 Vor Biopharma shares in Q3 2026, an estimated $2.75K.
  • Vor Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5185 holding.
  • Group One Trading first reported a position in Vor Biopharma in Q4 2023 and has held it in 8 quarters since.
  • Group One Trading's Vor Biopharma position peaked at $162K in Q1 2026.
  • 154 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.